Download Sample, Rising Surgical Procedures and Surge in Cosmetic Surgeries Drive the Non-invasive Surgical Wound Closure Market
As the number of surgical procedures both elective and emergency increases, there is a related rise in the need for effective wound closure options. This encompasses non-invasive techniques such as adhesives, staples, and bioengineered dressings, which are crucial for handling surgical sites and enhancing healing. Globally, about 310 million significant surgical procedures are conducted annually. The increasing use of minimally invasive surgical methods requires specific wound closure devices tailored for smaller cuts. Healthcare professionals are placing greater emphasis on patient-centered care, which highlights safety and aesthetic results. Methods of noninvasive closure minimize the likelihood of infections at the surgical site and encourage quicker healing, in line with the objectives of enhancing patient satisfaction and comfort.
Noninvasive surgical wound closure methods are essential in reducing the likelihood of infections at the surgical site and it has been reported that infections at surgical sites constitute 20% of all infections related to health and are linked to a 2 to 11 times higher risk of death. Surgical site infection represents the most expensive type of infection, with an estimated yearly expense of US$3.3 billion and it prolongs hospital stays by 9.7 days, resulting in an increase of over US$20,000 in hospitalization costs per admission. Noninvasive closure techniques establish a shield that safeguards the wound from outside contaminants. By preventing the skin from being punctured, as happens with sutures, these methods restrict avenues for bacteria to infiltrate the wound area, consequently lowering the chances of infection.
Cosmetic procedures including facelifts, eyelid surgeries, and body contouring, frequently emphasize minimally invasive techniques. Non-surgical wound closure options like adhesive strips and bioengineered dressings correspond with this inclination by offering effective closure without traditional sutures or staples which may result in more prominent scars. For instance, in June 2024, The International Society of Aesthetic Plastic Surgery published the findings of its yearly Global Survey on Aesthetic/Cosmetic Procedures, revealing a notable rise of 5.5% in surgical procedures with over 15.8 million operations carried out by plastic surgeons and 19.1 million non-surgical procedures.
Patients who undergo cosmetic procedures usually look for outcomes that reduce visible scarring. Non-invasive closures are intended to produce fewer or no scars, which is especially desirable in aesthetic surgeries where appearance is crucial. The capability to achieve neater closures improves patient satisfaction and promotes the use of these techniques. Non-invasive wound closure methods enable swifter healing compared to conventional approaches. As patients progressively seek quicker recovery and less interruption after cosmetic treatments, these techniques grow in appeal. They remove the need for painful stitch removals and lessen post-operative discomfort, leading to a more positive overall experience.
Noninvasive surgical wound closure methods are essential in reducing the likelihood of infections at the surgical site and it has been reported that infections at surgical sites constitute 20% of all infections related to health and are linked to a 2 to 11 times higher risk of death. Surgical site infection represents the most expensive type of infection, with an estimated yearly expense of US$3.3 billion and it prolongs hospital stays by 9.7 days, resulting in an increase of over US$20,000 in hospitalization costs per admission. Noninvasive closure techniques establish a shield that safeguards the wound from outside contaminants. By preventing the skin from being punctured, as happens with sutures, these methods restrict avenues for bacteria to infiltrate the wound area, consequently lowering the chances of infection.
Cosmetic procedures including facelifts, eyelid surgeries, and body contouring, frequently emphasize minimally invasive techniques. Non-surgical wound closure options like adhesive strips and bioengineered dressings correspond with this inclination by offering effective closure without traditional sutures or staples which may result in more prominent scars. For instance, in June 2024, The International Society of Aesthetic Plastic Surgery published the findings of its yearly Global Survey on Aesthetic/Cosmetic Procedures, revealing a notable rise of 5.5% in surgical procedures with over 15.8 million operations carried out by plastic surgeons and 19.1 million non-surgical procedures.
Patients who undergo cosmetic procedures usually look for outcomes that reduce visible scarring. Non-invasive closures are intended to produce fewer or no scars, which is especially desirable in aesthetic surgeries where appearance is crucial. The capability to achieve neater closures improves patient satisfaction and promotes the use of these techniques. Non-invasive wound closure methods enable swifter healing compared to conventional approaches. As patients progressively seek quicker recovery and less interruption after cosmetic treatments, these techniques grow in appeal. They remove the need for painful stitch removals and lessen post-operative discomfort, leading to a more positive overall experience.
Innovations in Product Development Providing Diverse Offerings in the Market
Innovations in products sourced from natural materials are offering considerable prospects in the non-invasive surgical wound closure market. These developments utilize the distinct characteristics of natural substances to promote wound healing, minimize complications, and enhance patient results. Natural items, like those sourced from silk fibroin or botanical extracts, are frequently biocompatible and hypoallergenic. For instance, in September 2024, SYLKE has recently garnered attention by introducing a significant advancement in post-surgical wound healing and obtaining US$5.5 million in initial funding. This groundbreaking product is the inaugural wound dressing crafted from pure hypoallergenic silk fibroin, aimed at improving healing in surgical wounds while reducing complications and infections that may result in unfavorable scarring results.
SYLKE has released findings from a study it carried out examining the efficacy of a silk surgical site wound closure prototype compared to conventional synthetic dressings. 75% of patients experienced partial or complete detachment of post-surgery applied Steri-Strips, while 0% faced total detachment of the silk dressing and 18.8% had partial detachment of the silk prototype in the initial two weeks following surgery. 20.8% of patients were evaluated by surgeons as showing erythema at the surgical site on the side of the body where Steri-Strip closure was employed, while 0% exhibited erythema on the silk prototype side.
As customers and healthcare professionals place greater emphasis on sustainability, organic products provide an environmentally friendly substitute for synthetic substances. Developments that concentrate on obtaining biodegradable and renewable resources can attract eco-aware consumers and organizations. This trend corresponds with wider movements towards sustainable healthcare practices, establishing a specialized market for natural wound closure products. Recent improvements in extraction and formulation techniques have increased the effectiveness of natural goods in wound care uses. For instance, novel approaches for extracting active substances from plants can amplify their healing impacts while preserving their natural characteristics. These technological advancements facilitate the creation of more efficient non-invasive wound closure solutions that utilize the advantages of nature.
SYLKE has released findings from a study it carried out examining the efficacy of a silk surgical site wound closure prototype compared to conventional synthetic dressings. 75% of patients experienced partial or complete detachment of post-surgery applied Steri-Strips, while 0% faced total detachment of the silk dressing and 18.8% had partial detachment of the silk prototype in the initial two weeks following surgery. 20.8% of patients were evaluated by surgeons as showing erythema at the surgical site on the side of the body where Steri-Strip closure was employed, while 0% exhibited erythema on the silk prototype side.
As customers and healthcare professionals place greater emphasis on sustainability, organic products provide an environmentally friendly substitute for synthetic substances. Developments that concentrate on obtaining biodegradable and renewable resources can attract eco-aware consumers and organizations. This trend corresponds with wider movements towards sustainable healthcare practices, establishing a specialized market for natural wound closure products. Recent improvements in extraction and formulation techniques have increased the effectiveness of natural goods in wound care uses. For instance, novel approaches for extracting active substances from plants can amplify their healing impacts while preserving their natural characteristics. These technological advancements facilitate the creation of more efficient non-invasive wound closure solutions that utilize the advantages of nature.
Recent Trends in Non-invasive Surgical Wound Closure Market
- Growing preference for adhesives that facilitate quicker wound closure and are less likely to cause allergic reactions
- Rise of scar less surgery approaches
- Integration of natural sources into wound closure products
- Increased focus on aesthetic outcomes that prioritize patient appearance
- Zip tie skin closure systems that allow for precise tension control during wound closure
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
High Cost of Products and Limited Awareness Pose Threat to the Market
The elevated expense of non-invasive surgical wound closure products presents a considerable challenge to the market, affecting adoption rates and overall development. The steep cost of advanced non-invasive wound closure products can limit their utilization in smaller healthcare facilities, including community hospitals and clinics. These establishments frequently function with stricter financial plans and might choose more cost-effective traditional methods over pricey innovative options, restricting market entry. Numerous healthcare providers encounter budget limitations that hinder their ability to invest in expensive wound closure products. This financial restriction can result in a tendency towards conventional sutures and staples, which are generally more budget-friendly and known to practitioners.
In developing markets, where sensitivity to costs is greater, the financial burden associated with advanced wound closure products can greatly influence demand. Healthcare providers in these areas might choose traditional approaches due to concerns over affordability, constraining the market's growth potential. The perceived worth of non-invasive wound closure products needs to validate their elevated prices. If healthcare providers do not perceive a distinct benefit in terms of patient outcomes, fewer complications, or overall cost efficiency when compared to traditional methods, they may hesitate to embrace these advancements. High prices can pose challenges in competing with established traditional methods that are familiar and commonly utilized. Consequently, producers of non-invasive wound closure products must successfully convey the benefits and advantages of their products to address resistance rooted solely in cost.
Limited understanding of non-invasive surgical wound closure products represents a major obstacle to the market's development and acceptance. Numerous healthcare providers might not be aware of the newest non-invasive wound closure methods and products. This deficiency in knowledge may result in a dependence on traditional techniques, such as sutures and staples, which they have utilized for many years. As a result, the shift toward non-invasive alternatives is obstructed, hindering market entry. The effective use of noninvasive wound closure products frequently necessitates specialized training. If healthcare professionals are not sufficiently informed about the advantages, application methods, and efficiency of these products, they may be hesitant to integrate them into their practice. This shortfall in training can restrict the overall embrace of innovative solutions in clinical environments.
In developing markets, where sensitivity to costs is greater, the financial burden associated with advanced wound closure products can greatly influence demand. Healthcare providers in these areas might choose traditional approaches due to concerns over affordability, constraining the market's growth potential. The perceived worth of non-invasive wound closure products needs to validate their elevated prices. If healthcare providers do not perceive a distinct benefit in terms of patient outcomes, fewer complications, or overall cost efficiency when compared to traditional methods, they may hesitate to embrace these advancements. High prices can pose challenges in competing with established traditional methods that are familiar and commonly utilized. Consequently, producers of non-invasive wound closure products must successfully convey the benefits and advantages of their products to address resistance rooted solely in cost.
Limited understanding of non-invasive surgical wound closure products represents a major obstacle to the market's development and acceptance. Numerous healthcare providers might not be aware of the newest non-invasive wound closure methods and products. This deficiency in knowledge may result in a dependence on traditional techniques, such as sutures and staples, which they have utilized for many years. As a result, the shift toward non-invasive alternatives is obstructed, hindering market entry. The effective use of noninvasive wound closure products frequently necessitates specialized training. If healthcare professionals are not sufficiently informed about the advantages, application methods, and efficiency of these products, they may be hesitant to integrate them into their practice. This shortfall in training can restrict the overall embrace of innovative solutions in clinical environments.
Product Launches and Advances in Technology Hold the Potential to Transform the Market
FDA approvals can result in a surge of new products available in the market, enhancing competition between manufacturers. This rivalry frequently stimulates innovation, resulting in improved products and possibly reduced prices for consumers as businesses work to set themselves apart. In May 2022, Advanced Medical Solutions Group plc has obtained FDA approval for LiquiBand XL, an innovative device designed to close longer wounds compared to current LiquiBand offerings and the device includes a surgical mesh that is utilized to close the wound, along with LiquiBand glue that is applied to enhance the closure and inhibit infection. The device has been effectively utilized in several orthopedic operations across various regions.
Agreements frequently enable collaborative research and development initiatives, permitting companies to pool resources, knowledge, and technologies. This can result in accelerated innovation cycles and the creation of more sophisticated non-invasive surgical wound closure products. For instance, in December 2024, BRIJ Medical, Inc received a national group purchasing agreement for breakthrough technology in the non-invasive skin closure sector with Premier, Inc. This new agreement permits Premier members, at their option, to benefit from special pricing and terms that have been pre-negotiated by Premier for the Brijjit BP-100 and BP-75 force-modulating tissue bridges. Premier provides breakthrough technology designations to innovations that deliver significant benefits regarding patient safety, clinical outcomes, and operational efficiencies.
Agreements frequently enable collaborative research and development initiatives, permitting companies to pool resources, knowledge, and technologies. This can result in accelerated innovation cycles and the creation of more sophisticated non-invasive surgical wound closure products. For instance, in December 2024, BRIJ Medical, Inc received a national group purchasing agreement for breakthrough technology in the non-invasive skin closure sector with Premier, Inc. This new agreement permits Premier members, at their option, to benefit from special pricing and terms that have been pre-negotiated by Premier for the Brijjit BP-100 and BP-75 force-modulating tissue bridges. Premier provides breakthrough technology designations to innovations that deliver significant benefits regarding patient safety, clinical outcomes, and operational efficiencies.
Searching for a Country or Region Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
North America Dominates the Non-invasive Surgical Wound Closure Market Driven by Increasing Number of Surgeries
North America leads the noninvasive surgical wound closure market because of several important factors that enhance its significant market share and growth opportunities. North America possesses a robust healthcare system with advanced medical technologies and facilities. This framework facilitates the use of groundbreaking noninvasive wound closure products, making them easily accessible to healthcare providers as well as patients, and the area sees a large volume of surgical procedures that include both elective and nonelective surgeries. For instance, the United States conducts between 40 and 50 million major surgical procedures annually.
An older population leads to a greater occurrence of chronic illnesses and conditions that necessitate surgical treatment. This demographic change raises the demand for surgical operations, consequently heightening the need for non-invasive wound closure techniques that correspond with patients’ desires for less invasive alternatives. There is a notable rise in cosmetic procedures in North America, where individuals look for minimally invasive choices that provide aesthetic advantages. Non-invasive wound closure techniques are especially preferred in cosmetic surgery because of their capacity to lessen scarring and enhance recovery durations. For instance, in 2024, the United States executed more than 7.4 million cosmetic procedures, encompassing both surgical and non-surgical treatments.
An older population leads to a greater occurrence of chronic illnesses and conditions that necessitate surgical treatment. This demographic change raises the demand for surgical operations, consequently heightening the need for non-invasive wound closure techniques that correspond with patients’ desires for less invasive alternatives. There is a notable rise in cosmetic procedures in North America, where individuals look for minimally invasive choices that provide aesthetic advantages. Non-invasive wound closure techniques are especially preferred in cosmetic surgery because of their capacity to lessen scarring and enhance recovery durations. For instance, in 2024, the United States executed more than 7.4 million cosmetic procedures, encompassing both surgical and non-surgical treatments.
The report provides a detailed overview of the non-invasive surgical wound closure market insights in regions including North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa. The country-specific assessment for the non-invasive surgical wound closure market has been offered for all regional market shares, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the non-invasive surgical wound closure market. These Y-o-Y projections on regional and country-level markets brighten the political, economic, and business environment outlook, which are anticipated to have a substantial impact on the growth of the non-invasive surgical wound closure market. Some key countries and regions included in the non-invasive surgical wound closure market report are as follows:
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Non-invasive Surgical Wound Closure Market Research Report Covers In-depth Analysis on:
- Non-invasive surgical wound closure market detailed segments and segment-wise market breakdown
- Non-invasive surgical wound closure market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in non-invasive surgical wound closure industry)
- Current, historical and forthcoming 10 years market valuation in terms of non-invasive surgical wound closure market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Non-invasive surgical wound closure market demand analysis
- Non-invasive surgical wound closure market pricing analysis over the forecast period (by key segment and by region)
- Non-invasive surgical wound closure market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in non-invasive surgical wound closure market
- Regulatory landscape by key regions and key countries
- Supply chain and value chain analysis in non-invasive surgical wound closure market
- Non-invasive surgical wound closure market sales and distribution strategies
- A comprehensive overview of the parent market
- A detailed viewpoint on noninvasive surgical wound closure market forecast by countries
- Mergers and acquisitions in non-invasive surgical wound closure market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What are the key drivers of the Non-invasive Surgical Wound Closure market growth?
Advancements in wound care technologies, an increase in surgical procedures, and rising demand for effective and minimally painful treatments are some of the key drivers fueling the market growth.
Which industries are primarily contributing to the Non-invasive Surgical Wound Closure market?
The healthcare and medical device industries are the primary contributors, including hospitals, clinics, and outpatient care centers that adopt non-invasive wound closure solutions for various surgical and trauma-related wounds.
What is the future outlook for the Non-invasive Surgical Wound Closure market?
The market is expected to expand due to continuous innovations in medical technology, growing awareness of non-invasive procedures, and the increasing preference for painless, effective wound healing options.
